Daniel Lee Flynn - Jan 17, 2023 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc. (DCPH)

Role
Chief Scientific Officer
Signature
/s/ Jeffrey M. Held, Attorney-in-Fact
Stock symbol
DCPH
Transactions as of
Jan 17, 2023
Transactions value $
-$51,043
Form type
4
Date filed
1/19/2023, 03:06 PM
Previous filing
Jun 21, 2022
Next filing
Feb 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DCPH Common Stock Sale -$51K -2.4K -5.21% $21.24 43.7K Jan 17, 2023 Direct F1
holding DCPH Common Stock 230K Jan 17, 2023 By Daniel L. Flynn Revocable Trust
holding DCPH Common Stock 91K Jan 17, 2023 By Daniel L. Flynn Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was to cover tax liabilities in the vesting of restricted stock.